$0.9950
0.06857.39%
Last update: Nov 9, 5:02 AM
Cardiol Therapeutics Inc
CRDLNASDAQ
The average analyst price target for Cardiol Therapeutics is $9.50, 804.8% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $9 to $10. The latest change came on Aug 17, 2026, when Canaccord Genuity raised its price target on Cardiol Therapeutics from $8 to $10 and kept a Buy rating.
Price Target Range — 8 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
